HPV (Human Papillomavirus) types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 (DNA, screening test, swab/M)
We remind you that independent interpretation of the results is unacceptable; the information below is for reference only.
Human papillomavirus (HPV) high-risk screening (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) is a molecular diagnostic test used to detect HPV DNA in urogenital samples in men. The test identifies high-risk HPV types associated with the development of precancerous lesions and anogenital cancers.
Indications
- Anogenital warts (condylomas)
- Suspicion of HPV infection
- Sexual contact with an HPV-positive partner
- Chronic urogenital inflammatory conditions
- Routine screening
- Evaluation in cases of infertility or reduced fertility
- Screening in the presence of oncogenic risk factors
Procedure
- Collection of urethral and/or anogenital swab
- Performed by a healthcare professional
- Takes a few minutes
- Mild, temporary discomfort may occur
Method of testing
The test is performed using PCR (polymerase chain reaction), which detects high-risk HPV DNA types. This method is highly sensitive and can detect infection even at low viral loads.
Sources:
https://www.cdc.gov/std/treatment-guidelines/hpv-cancer.htm
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812266/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373819/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077029/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561418/
IMPORTANT!
It is crucial to remember that the information provided in this section is not intended for self-diagnosis or treatment. If you experience pain or an exacerbation of a medical condition, it is essential to consult a doctor for diagnostic testing and appropriate treatment. Only a qualified specialist can make an accurate diagnosis and determine the appropriate treatment. To ensure the most accurate and consistent evaluation of test results, it is recommended to have them performed at the same laboratory. This is because different laboratories may use various methods and units of measurement for similar tests.
Preparation:
- Avoid sexual intercourse for 48 hours before the test
- Do not urinate 2–3 hours prior to sampling
- Do not use antiseptic or topical treatments before the test
- Avoid antibiotics for 7–14 days prior (as advised by a doctor)